Demin Yu

1.3k total citations
39 papers, 942 citations indexed

About

Demin Yu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Demin Yu has authored 39 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Demin Yu's work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (11 papers). Demin Yu is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (11 papers). Demin Yu collaborates with scholars based in China, Japan and France. Demin Yu's co-authors include Xinxin Zhang, Yue Han, Qiming Gong, Xinge Zhang, Zhongming Wu, Donghua Zhang, Mingjie Wang, Li Chen, Qiang Deng and Chaoxing Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Demin Yu

38 papers receiving 928 citations

Peers

Demin Yu
Abbas Behzad‐Behbahani Iran
E. Walter Germany
Rodolphe Carpentier France
Carole Fournier France
Tsunamasa Watanabe Japan
Dmitry Kostyushev Russia
Dianxing Sun China
Darong Yang China
Yongge Wu China
Abbas Behzad‐Behbahani Iran
Demin Yu
Citations per year, relative to Demin Yu Demin Yu (= 1×) peers Abbas Behzad‐Behbahani

Countries citing papers authored by Demin Yu

Since Specialization
Citations

This map shows the geographic impact of Demin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demin Yu more than expected).

Fields of papers citing papers by Demin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demin Yu. The network helps show where Demin Yu may publish in the future.

Co-authorship network of co-authors of Demin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Demin Yu. A scholar is included among the top collaborators of Demin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demin Yu. Demin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jing, Lihong Qu, Xuehua Sun, et al.. (2021). Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients. Journal of Viral Hepatitis. 28(10). 1381–1391. 8 indexed citations
2.
Ye, Fei, Wei Huang, Yuan Xue, et al.. (2021). Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection. SHILAP Revista de lepidopterología. Volume 8. 285–300. 4 indexed citations
3.
Wang, Mingjie, et al.. (2020). Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19. Frontiers in Immunology. 11. 565278–565278. 31 indexed citations
4.
Wang, Mingjie, Jianfeng Li, Xiaonan Zhang, et al.. (2020). An integrated software for virus community sequencing data analysis. BMC Genomics. 21(1). 363–363. 4 indexed citations
5.
Huang, Wei, Mingjie Wang, Qiming Gong, et al.. (2019). Comparison of Naturally Occurring Resistance-Associated Substitutions Between 2008 and 2016 in Chinese Patients with Chronic Hepatitis C Virus Infection. Microbial Drug Resistance. 25(6). 944–950. 7 indexed citations
6.
Wang, Mingjie, Qiming Gong, Jiming Zhang, et al.. (2017). Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Scientific Reports. 7(1). 43446–43446. 76 indexed citations
7.
8.
Silvestre, Nathalie, Demin Yu, Yue Han, et al.. (2015). The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China. Archives of Virology. 160(4). 1125–1130. 5 indexed citations
9.
10.
Guo, Qianqian, et al.. (2013). Glucose-sensitive polyelectrolyte nanocapsules based on layer-by-layer technique for protein drug delivery. Journal of Materials Science Materials in Medicine. 25(1). 121–129. 25 indexed citations
11.
Yu, Demin, Xinhua Li, Yue Han, et al.. (2013). N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape. Journal of Hepatology. 60(3). 515–522. 70 indexed citations
12.
13.
Kuno, Atsushi, Atsushi Matsuda, Demin Yu, et al.. (2012). Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels. Clinica Chimica Acta. 413(21-22). 1796–1799. 9 indexed citations
14.
15.
Ioannou, Yiannis, Jingyun Zhang, Miao Qi, et al.. (2011). Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2‐glycoprotein I. Arthritis & Rheumatism. 63(9). 2774–2782. 84 indexed citations
16.
Wu, Zhongming, et al.. (2011). Phenylboronic Acid Grafted Chitosan as a Glucose-Sensitive Vehicle for Controlled Insulin Release. Journal of Pharmaceutical Sciences. 100(6). 2278–2286. 54 indexed citations
17.
Chen, Li, Qian Zhang, Demin Yu, Mobin Wan, & Xinxin Zhang. (2009). Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy. Journal of Hepatology. 50(5). 895–905. 55 indexed citations
18.
Zhang, Xinxin, Gang Hou, Qiang Deng, et al.. (2008). Assessment of Specific Antibodies to F Protein in Serum Samples from Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin. Journal of Clinical Microbiology. 46(11). 3746–3751. 20 indexed citations
19.
Yu, Demin, Penghua Wang, Shuliang Lu, et al.. (2008). [Impact of advanced glycosylation end products-modified human serum albumin on migration of epidermal keratinocytes: an in vitro experiment].. PubMed. 88(38). 2690–4. 6 indexed citations
20.
Yu, Pei, Demin Yu, Jing Wang, et al.. (2006). [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].. PubMed. 86(48). 3425–30. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abbas Behzad‐Behbahani Breakdown of academic impact, for papers by E. Walter Breakdown of academic impact, for papers by Rodolphe Carpentier Breakdown of academic impact, for papers by Carole Fournier Breakdown of academic impact, for papers by Tsunamasa Watanabe Breakdown of academic impact, for papers by Dmitry Kostyushev Breakdown of academic impact, for papers by Dianxing Sun Breakdown of academic impact, for papers by Darong Yang Breakdown of academic impact, for papers by Yongge Wu
Rankless by CCL
2026